These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7554707)

  • 1. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
    Abernethy DR; Laurie N; Andrawis NS
    Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging is associated with endothelial dysfunction in the human forearm vasculature.
    Andrawis N; Jones DS; Abernethy DR
    J Am Geriatr Soc; 2000 Feb; 48(2):193-8. PubMed ID: 10682949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
    Cockcroft JR; Allen MJ; Benjamin N; Webb DJ
    J Hum Hypertens; 1989 Feb; 3(1):49-52. PubMed ID: 2542549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
    Postma CT; Maessen SM; Thien T; Smits P
    Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels.
    Webb DJ; Collier JG; Seidelin PH; Struthers AD
    J Hypertens Suppl; 1988 Dec; 6(3):S57-9. PubMed ID: 2852237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
    Kiowski W; Linder L; Erne P
    J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
    Sim JS; Dick JB; Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
    Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ
    J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
    Hulthén UL; Bolli P; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent vasoconstrictor effects and clearance of endothelin in the human forearm.
    Pernow J; Hemsén A; Lundberg JM; Nowak J; Kaijser L
    Acta Physiol Scand; 1991 Mar; 141(3):319-24. PubMed ID: 1858504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct angiotensin converting enzyme inhibitor-mediated venodilation.
    Zarnke KB; Feldman RD
    Clin Pharmacol Ther; 1996 May; 59(5):559-68. PubMed ID: 8646827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of endogenous generation of endothelin-1 to basal vascular tone.
    Haynes WG; Webb DJ
    Lancet; 1994 Sep; 344(8926):852-4. PubMed ID: 7916401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.
    Newby DE; Masumori S; Johnston NR; Boon NA; Webb DJ
    Cardiovasc Res; 1997 Nov; 36(2):268-75. PubMed ID: 9463638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation.
    McNeill JR
    Can J Physiol Pharmacol; 2003 Jun; 81(6):522-32. PubMed ID: 12839264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.